English
新闻公告
More
化学进展 2009, Vol. 21 Issue (05): 896-902 前一篇   后一篇

• 金属药物专辑 •

钒化合物抗糖尿病作用的研究进展*

韦丹; 丁文军**; 周桔 ;彭端 ;李明   

  1. (中国科学院研究生院生命科学学院环境与健康研究室    北京   100049)
  • 收稿日期:2009-02-03 修回日期:2009-01-27 出版日期:2009-05-24 发布日期:2009-05-05
  • 通讯作者: 丁文军 E-mail:dingwj@gucas.ac.cn
  • 基金资助:

    国家自然科学基金

Research Progress in Anti-Diabetic Effects of Vanadium Compounds

Wei Dan; Ding Wenjun**; Zhou Ju; Peng Duan; Li Ming   

  1. (Laboratory of Environment and Health, College of Life Sciences, Graduate University of Chinese Academy of Sciences, Beijing 100049, China)
  • Received:2009-02-03 Revised:2009-01-27 Online:2009-05-24 Published:2009-05-05
  • Contact: Ding Wenjun E-mail:dingwj@gucas.ac.cn

在糖尿病的治疗研究中,体内和体外的研究表明,钒化合物可以降低I型和II型糖尿病血糖,促进葡萄糖转运和糖原合成,具有“类胰岛素作用”。本文综述了近年来钒化合物在降低和改善糖尿病症状的生物效应及其通过胰岛素信号通路在降糖作用的分子机制的研究进展。

It is well known that diabetes mellitus (DM) is a chronic disease caused by inherited and/or acquired deficiency in production of insulin by the pancreas, or by the ineffectiveness of the insulin produced. Numerous studies have shown that vanadium and its compounds improve glucose homeostasis and insulin resistance in Type I and Type II diabetes mellitus. Vanadium and its compounds appear to have a profound impact on insulin action through the insulin signaling cascade, but the underlying mechanism is not fully understood. This review summarizes recent work to identify the effects of pharmaceutical treatment of vanadium compounds on insulin signaling and glucose uptake, in an attempt to characterize the molecular mechanism accounting for biological actions and insulin-mimesis of vanadium compounds in DM.

Contents
1 Introduction
2 Chemical properties of vanadium and anti-diabetic actions of vanadium compounds
2.1 Chemical properties of vanadium
2.2 Anti-diabetic actions of vanadium compounds
3 Mechanism of anti-diabetic effects of vanadium compounds
3.1 Coordination chemistry of vanadium compounds
3.2 Vanadium compounds and PTP1B
3.3 Vanadium compounds and glucose transport
3.4 Vanadium compounds and metabolism of glycogen and lipid
3.5 Molecular mechanism of insulin-mimetic action of vanadium compounds
4 Issues and perspective

中图分类号: 

()

[ 1 ]  Proietto J , Nankervis A , Aitken P , Caruso G, et al . Diabetologia ,1983 , 25 : 331 —335
[ 2 ]  Chan J C , Deerochanawong C , Shera A S , et al . Diabetes Res.Clin. Pract . , 2007 , 75 : 255 —266
[ 3 ]  Tabatabai A , Li S. Clin. Excell . Nurse Pract . , 2000 , 4 : 272 —276
[ 4 ]  Yang L , Crans D C , Miller S M, et al . Inorg. Chem. , 2002 , 41 :4859 —4871
[ 5 ]  Nakamura J , Hamada Y, Chaya S , et al . Diabetes Metab. Res.Rev. , 2002 , 18 : 395 —402
[ 6 ]  Kadota S , Fantus I G, Deragon G, et al . Biochem. Biophys. Res.Commun. , 1987 , 147 : 259 —266
[ 7 ]  Harland B F , Harden-Williams B A. J . Am. Diet Assoc. , 1994 ,94 : 891 —894
[ 8 ]  Meisch H U , Bielig HJ . Basic Res. Cardiol . , 1980 , 75 : 413 —417
[ 9 ]  Rau M, Patole M S , Vijaya S , et al . Mol . Cell Biochem. , 1987 ,75 : 151 —159
[10 ]  Nechay B R. Annu. Rev. Pharmacol . Toxicol . , 1984 , 24 : 501 —524
[11 ]  Heyliger C E , Tahiliani A G, McNeill J H. Science , 1985 , 227 :1474 —1477
[12 ]  Brichard S M, Okitolonda W, Henquin J C. Endocrinology , 1988 ,123 : 2048 —2053
[13 ]  Meyerovitch J , Farfel Z, Sack J , et al . J . Biol . Chem. , 1987 ,262 : 6658 —6662
[14 ]  Paulson DJ , Kopp SJ , TowJ P , et al . J . Pharmacol . Exp. Ther. ,1987 , 240 : 529 —534
[15 ]  Sakurai H , Tsuchiya K, Orvig C , et al . J . Endocrinol . , 1990 ,126 : 451 —459
[16 ]  Domingo J L. Reprod. Toxicol . , 1996 , 10 : 175 —182
[17 ]  McNeill J H , Yuen V G, Hoveyda H R , et al . J . Med. Chem. ,1992 , 35 : 1489 —1491
[18 ]  Cam M C , Cros G H , Serrano J J , et al . Diabetes Res. Clin.Pract . , 1993 , 20 : 111 —121
[19 ]  Li M, Wei D , Ding W, et al . Biol . Trace Elem. Res. , 2008 , 121 :226 —232
[20 ]  Shukla R , Padhye S , Modak M, et al . Rev. Diabet . Stud. , 2007 ,4 : 33 —43
[21 ]  Takino T, Yasui H , Yoshitake A , et al . J . Biol . Inorg. Chem. ,2001 , 6 : 133 —142
[22 ]  Xie M, Xu G, Li L , et al . Eur. J . Med. Chem. , 2007 , 42 :817 —822
[23 ]  Yuan M, Yu B , Liang Y. Chin. Med. J . , 1997 , 110 : 715 —719
[24 ]  Yuen V G, Orvig C , McNeill J H. Can. J . Physiol . Pharmacol . ,1993 , 71 : 263 —269
[25 ]  Kordowiak A M, Trzos R , Grybos R. Horm. Metab. Res. , 1997 ,29 : 101 —105
[26 ]  Zuo YQ , Liu W P , Niu Y F , et al . J . Pharm. Pharmacol . , 2008 ,60 : 1335 —1340
[27 ]  Crans D C. J . Inorg. Biochem. , 2000 , 80 : 123 —131
[28 ]  Zhang S Q , Chen G H , Lu WL , et al . J . Bone Miner. Metab. ,2007 , 25 : 293 —301
[29 ]  Brichard S M, Bailey C J , Henquin J C. Diabetes , 1990 , 39 :1326 —1332
[30 ]  Meyerovitch J , Rothenberg P , Shechter Y, et al . J . Clin. Invest . ,1991 , 87 : 1286 —1294
[31 ]  Adachi Y, Yoshikawa Y, Yoshida J , et al . Biochem. Biophys. Res.Commun. , 2006 , 345 : 945 —950
[32 ]  Cusi K, Cukier S , DeFronzo R A , et al . J . Clin. Endocrinol .Metab. , 2001 , 86 : 1410 —1417
[33 ]  Sun Q , Sekar N , Goldwaser I , et al . Am. J . Physiol . Endocrinol .Metab. , 2000 , 279 : E403 —E410
[34 ]  Yuen V G, Pederson R A , Dai S , et al . Can. J . Physiol .Pharmacol . , 1996 , 74 : 1001 —1009
[35 ]  Goldfine A B , Patti M E , Zuberi L , et al . Metabolism , 2000 , 49 :400 —410
[36 ]  Karmaker S , Saha T K, Yoshikawa Y, et al . Chem. Med. Chem. ,2007 , 2 : 1607 —1612
[37 ]  Saha T K, Yoshikawa Y, Sakurai H. J . Pharm. Pharmacol . , 2007 ,59 : 437 —444
[38 ]  Sakurai H. Yakugaku Zasshi , 2008 , 128 : 317 —322
[39 ]  Wasan KM, Risovic V , Yuen V G, et al . J . Trace Elem. Med.Biol . , 2006 , 19 : 251 —258
[40 ]  Woo L C , Yuen V G, Thompson K H , et al . J . Inorg. Biochem. ,1999 , 76 : 251 —257
[41 ]  Scior T, Guevara2Garcia A , Bernard P , et al . Mini . Rev. Med.Chem. , 2005 , 5 : 995 —1008
[42 ]  Denu J M, Lohse D L , Vijayalakshmi J , et al . Proc. Natl . Acad.Sci . USA. , 1996 , 93 : 2493 —2498
[43 ]  Denu J M, Tanner K G. Biochemistry , 1998 , 37 : 5633 —5642
[44 ]  Bevan A P , Drake P G, Yale J F , et al . Mol . Cell . Biochem. ,1995 , 153 : 49 —58
[45 ]  Dabros W, Dziga D , Kordowiak A M. Pol . J . Pathol . , 2002 , 53 :205 —213
[46 ]  Huyer G, Liu S , Kelly J , et al . J . Biol . Chem. , 1997 , 272 :843 —851
[47 ]  Winter CL , Lange J S , DavisM G, et al . Exp. Biol . Med. , 2005 ,230 : 207 —216
[48 ]  Tracey A S. J . Inorg. Biochem. , 2000 , 80 : 11 —16
[49 ]  Li M, Ding W, Baruah B , et al . J . Inorg. Biochem. , 2008 , 102 :1846 —1853
[50 ]  Paquet M R , Romanek R J , Sargeant R J . Mol . Cell . Biochem. ,1992 , 109 : 149 —155
[51 ]  Clausen T, Andersen T L , Sturup-Johansen M, et al . Biochim.Biophys. Acta , 1981 , 646 : 261 —267
[52 ]  Cuncic C , Desmarais S , Detich N , et al . Biochem. Pharmacol . ,1999 , 58 : 1859 —1867
[53 ]  Berger J , Hayes N , Szalkowski D M, et al . Biochem. Biophys.Res. Commun. , 1994 , 205 : 570 —576
[54 ]  Brichard S M, Assimacopoulos-Jeannet F , Jeanrenaud B , et al .Endocrinology , 1992 , 131 : 311 —317
[55 ]  Sekar N , Li J , He Z, et al . Endocrinology , 1999 , 140 : 1125 —1131
[56 ]  Tsiani E , Bogdanovic E , Sorisky A , et al . Diabetes , 47 : 1998 ,1676 —1686
[57 ]  Horovitz-Fried M, Brutman-Barazani T, Kesten D , et al .Endocrinology , 2008 , 149 : 1718 —1727
[58 ]  Makinen M W, Brady MJ . J . Biol . Chem. , 2002 , 277 : 12215 —12220
[59 ]  Evangelia T, Elena B , Alexander S , et al . Diabetes , 1998 , 47 :1676 —1686
[60 ]  Chen J , Lu G, Wang Q J . Mol . Pharmacol . , 2005 , 67 : 152 —162
[61 ]  Nolte L A , Han D H , Hansen P A , et al . Diabetes , 2003 , 52 :1918 —1925
[62 ]  Pugazhenthi S , Khandelwal R L. Diabetes , 1990 , 39 : 821 —827
[63 ]  Wei D , Li M, Ding W. J . Biol . Inorg. Chem. , 2007 , 12 : 1265 —1273
[64 ]  Khandelwal RL , Pugazhenthi S. Mol . Cell . Biochem. , 1995 , 153 :87 —94
[65 ]  Furnsinn C , Englisch R , Ebner K, et al . Life Sci . , 1996 , 59 :1989 —2000
[66 ]  Nakai M, Watanabe H , Fujiwara C , et al . Biol . Pharm. Bull . ,1995 , 18 : 719 —725
[67 ]  Li J , Elberg G, Sekar N , et al . Endocrinology , 1997 , 138 : 2274 —2279
[68 ]  Jung U J , Lee M K, Jeong K S , et al . J . Nutr. , 2004 , 134 :2499 —2503
[69 ]  Brichard S M, Desbuquois B , Girard J . Mol . Cell Endocrinol . ,1993 , 91 : 91 —97
[70 ]  Reul B A , Amin S S , Buchet J P , et al . British J . Pharm. , 1999 ,126 : 467 —477
[71 ]  Mosseri R , Waner T, Shefi M, et al . Metabolism , 2000 , 49 : 321 —325
[72 ]  Marzban L , Rahimian R , Brownsey R W, et al . Endocrinology ,2002 , 143 : 4636 —4645
[73 ]  Ferber S , Meyerovitch J , Kriauciunas K M, et al . Metabolism ,1994 , 43 : 1346 —1354
[74 ]  Sekar N , Li J , Shechter Y. Crit . Rev. Biochem. Mol . Biol . ,1996 , 31 : 339 —359
[75 ]  Niu Y, Liu W, Tian C , et al . Eur. J . Pharmacol . , 2007 , 572 :213 —219
[76 ]  Perez de Obanos M P , Lopez-Zabalza M J , Arriazu E , et al .Biochim. Biophys. Acta , 2007 , 1773 : 1681 —1688
[77 ]  Mehdi M Z, Azar Z M, Srivastava A K. Cell Biochem. Biophys. ,2007 , 47 : 1 —10
[78 ]  Azar Z M, Mehdi M Z, Srivastava A K. Can. J . Physiol .Pharmacol . , 2006 , 84 : 777 —786
[79 ]  Yang X G, Yang X D , Yuan L , et al . Pharm. Res. , 2004 , 21 :1026 —1033
[80 ]  Zhang Z, Huang C , Li J , et al . Arch. Biochem. Biophys. , 2001 ,392 : 311 —320
[81 ]  Cortizo A M, Bruzzone L , Molinuevo S , et al . Toxicology , 2000 ,147 : 89 —99
[82 ]  Pandey S K, Anand-Srivastava MB , Srivastava A K. Biochemistry ,1998 , 37 : 7006 —7014
[83 ]  Garcia-Vicente S , Yraola F , Marti L , et al . Diabetes , 2007 , 56 :486 —493
[84 ]  White M F. Am. J . Physiol . Endocrinol Metab. , 2002 , 283 :E413 —E422
[85 ]  Srivastava A K, Pandey S K. Mol . Cell Biochem. , 1998 , 182 :135 —141
[86 ]  Molero J C , Perez C , Martinez C , et al . Mol . Cell Endocrinol . ,2002 , 189 : 77 —84
[87 ]  Pandey S K, Theberge J F , Bernier M, et al . Biochemistry , 1999 ,38 : 14667 —14675
[88 ]  Adachi Y, Yoshida J , Kodera Y, et al . J . Med. Chem. , 2006 ,49 : 3251 —3256
[89 ]  Li Y, Hao P , Zhang S , et al . Nucleic Acid Res. , 2008 , 36 :E137 —E145

[1] 韩毅, 董海青, 李胜, 李维达, 李永勇. 胰岛封装技术及其在胰岛移植中的应用[J]. 化学进展, 2018, 30(11): 1660-1668.
[2] 张宇琪, 俞计成, 沈群东, 顾臻. 随葡萄糖响应的合成类闭路胰岛素递释系统[J]. 化学进展, 2015, 27(1): 11-26.
[3] 周军, 白兆帅, 徐辉碧, 黄开勋*. 硒蛋白与糖尿病——硒的两面性[J]. 化学进展, 2013, 25(04): 488-494.
[4] 黄美玲, 武亚玲, 赵攀, 杨晓达*. 无机药物: 问题和解决思路[J]. 化学进展, 2013, 25(04): 650-660.
[5] 杨晓改,王琴,刘竟成,王夔. 从钒化合物生物效应的多样性看其作用机制*[J]. 化学进展, 2009, 21(05): 890-895.
[6] 杨晓改,杨晓达,王夔. 钒化合物生物效应的化学基础和药用前景__金属药物研究的化学问题[J]. 化学进展, 2002, 14(04): 279-.